Effects of extracorporeal photoimmunotherapy on soluble IL-2Rα, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host disease

Clinical Immunology

Volumn 104, Issue 3, 2002, Pages 248-255

  Kokalj, Alexandra ^a   Greinix, Hildegard T ^a   Ciovica, Marina ^a   Kittler, Harald ^a   Kalhs, Peter ^a   Knobler, Robert M ^a   Volc Platzer, Beatrix ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute GvHD; Extracorporeal photoimmunotherapy; Immune activation markers

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; STEROID; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0036751592     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5240     Document Type: Article

References (48)

1. Ferrara, J. L. M., and Deeg, H. J., Graft-versus-host disease. N. Engl. J. Med. 324, 667-674, 1991.
2. Beatty, P. G., Hansen, J. A., Longton, G. M. et al., Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51, 443-447, 1991.
3. Glucksberg, H., Storb, R., Fefer, A., Bruckner, C. D., Neiman, P. E., Clift, R. A. et al., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18, 295-304, 1974.
4. Rowlings, P. A., Przepiorka, D., Klein, J. P. et al., IBMTR Severity index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br. J. Haematol. 97, 855-864, 1997.
5. Lerner, K. G., Kao, G. F., Storb, R., Buckner, C. D., Clift, R. A., and Thomas, E. D., Histopathology of graft-versus-host reaction (GHVR) in human recipients of marrow from HLA-matched sibling donors. Transplant Proc. 6, 367-371, 1974.
6. Sullivan, K. M., Shulman, H. M., Storb, R. et al., Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 7, 267-276, 1981.
7. Krenger, W., Hill, G. R., Ferrara, J. L. M., Cytokine cascades in acute graft-versus-host disease. Transplantation 64, 553-558, 1997.
8. Korngold, R., and Sprent, J., T-cell subset and graft-versus-host disease. Transplantation 44, 335-339, 1987.
9. Krenger, W., and Ferrara, J. L. M., Graft-versus-host disease and the Th1/Th2 paradigm. Immunol. Res. 15, 50-73, 1996.
10. Reinherz, E. L., Parkman, R., Rappeport, J., Rosen, F. S., and Schlossman, S. F., Aberrations of suppressor T cells in human graft-versus-host disease. N. Engl. J. Med. 300, 1061-1068, 1979.
11. Parkman, R., Rappeport, J., and Rosen, F., Human graft-versus-host disease. J. Invest. Dermatol. 74, 276-279, 1980.
12. Doney, K. C., Weiden, P. L., Storb, R., and Thomas, E. D., Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomised trial comparing antithymocyte globulin and corticosteroids. Am. J. Hematol. 11, 1-8, 1981.
13. Hings, I. M., Severson, R., Filipovich, A. H. et al., Treatment of moderate and severe acute GvHD after allogeneic bone marrow transplantation. Transplantation 58, 437-442, 1994.
14. Racadot, E., Milpied, N., Bordigoni, P. et al., Sequential use of three monoclonal antibodies in corticosteroid-resistant acute graft-versus-host disease: A multicentric pilot study including 15 patients. Bone Marrow Transplant. 15, 669-677, 1995.
15. Kernan, N. A., Byers, V., Scannon, P. J. et al., Treatment of steroid-resistant acute graft-versus-host disease by in vivo administration of an anti-T cell ricin A chain immunotoxin. J. Am. Med. Assoc. 259, 3154-3157, 1988.
16. Herve, P., Wijdens, J., Bergerat, J. P. et al., Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-IL-2 receptor monoclonal antibody (B-B10). Blood 75, 1017-1023, 1990.
17. Przepiorka, D., Kernan, N. A., and Ippoliti, C., Daclizumab, a humanised anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 95, 83-89, 2000.
18. Hymes, S. R., Morison, W. L., Farmer, E. R., Walters, L. L., Tutschka, P. J., and Santos, G. W., Methoxypsoralen and ultraviolet a radiation in treatment of chronic graft-versus-host reaction. J. Am. Acad. Dermatol. 12, 30-37, 1985.
19. Atkinson, K., Weller, P., Ryman, W., and Biggs, J., PUVA therapy for drug-resistant graft-versus-host disease. Bone Marrow Transplant. 1, 227-236, 1986.
20. Volc-Platzer, B., Hönigsmann, H., Hinterberger, W., and Wolff, K., Photochemotherapy improves chronic cutaneous graft-versus-host disease. J. Am. Acad. Dermatol. 23, 220-228, 1990.
21. Eppinger, T., Ehninger, G., Steinert, M., Niethammer, D., and Dopfer, R., 8-methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease. Transplantation 50, 807-811, 1990.
22. Besnier, D. P., Chabannes, D., Mahé, B. et al., Treatment of graft-versus-host disease by extracorporeal photochemotherapy. Transplantation 4, 49-54, 1997.
23. Gerber, M., Gmeinhart, G., Volc-Platzer, B., Kalhs, P., Greinix, H., and Knobler, R., Complete remission of lichen-planus-like graft-versus-host disease with extracorporeal photochemotherapy. Bone Marrow Transplant. 19, 517-519, 1997.
24. Greinix, H. T., Volc-Platzer, B., Rabitsch, W. et al., Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host-disease. Blood 92, 3098-3104, 1998.
25. Greinix, H. T., Volc-Platzer, B., Kalhs, P. et al., Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: A pilot study. Blood 96, 2426-2431, 2000.
26. Edelson, R., Berger, C., Gasparro, F. et al., Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N. Engl. J. Med. 316, 297-303, 1987.
27. Rook, A. H., Suchin, K. R., Kao, D. M. F. et al., Photopheresis: Clinical applications and mechanism of action. J. Invest. Dermatol. 4, 85-90, 1999.
28. Barr, M. L., Meiser, B. M., Eisen, H. J. et al., Photopheresis for the prevention of rejection in cardiac transplantation. N. Engl. J. Med. 339, 1744-1751, 1998.
29. Tokura, Y., Yagi, J., Edelson, R. L., and Gasparro, F. P., Inhibitory effect of 8-methoxypsoralen plus ultraviolet-A on interleukin-1 production by murine keratinocytes. Photochem. Photobiol. 53, 517-523, 1991.
30. Mohamadzadeh, M., McGuire, M. J., Dougherty, I., and Cruz, P. D., Interleukin-15 expression by human endothelial cells: Up-regulation by ultraviolet B and psoralen plus ultraviolet A treatment. Photodermatol. Photoimmunol. Photomed. 12, 17-21, 1996.
31. Vowels, B. R., Cassin, M., Boufal, M. H., Walsh, L., and Rook, A. H., Extracorporeal photochemotherapy induces the production of tumor necrosis factor α by monocytes: Implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J. Invest. Dermatol. 98, 686-692, 1992.
32. Moor, A. C., Schmitt, I. M., Beijersbergen van Henegouwen, G. M., Chimenti, S., Edelson, R. L., and Gasparro, F. P., Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: Preliminary results. J. Photochem. Photobiol. 29, 193-198, 1995.
33. Knobler, R. M., Trautinger, F., Graniniger, W., Macheiner, W., Gruenwald, C., Neumann, R. et al., Parenteral administration of 8-methoxypsoralen in photopheresis. J. Am. Acad. Dermatol. 28, 580-584, 1993.
34. Yoo, E. K., Rook, A. H., Elenitsas, R., Gasparro, F. P., and Vowels, B. R., Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J. Invest. Dermatol. 107, 235-242, 1996.
35. Grimm, J., Zeller, W., Zander, A. R., Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD. Bone Marrow Transplant. 21, 29-32, 1998.
36. Siegert, W., Josimovic-Alasevic, O., Schwerdtfeger, R. et al., Soluble interleukin-2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant. 6, 97-101, 1990.
37. Foley, R., Couban, S., Walker, I., Greene, K., Chen, C. S., Messner, H. et al., Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation. Bone Marrow Transplant. 21, 769-773, 1998.
38. Miyamoto, T., Akashi, K., Hayashi, S. et al., Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant. 17, 185-190, 1996.
39. Liem, L. M., van Houwelingen, H. C., and Goulmy, E., Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation 66, 863-871, 1998.
40. Tiberghien, P., Racadot, E., Lioure, B. et al., Soluble CD8, II-2 receptor and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Transplantation 52, 475-481, 1991.
41. Ferrara, J. L. M., The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant. 21, S13-S15, 1998.
42. Holler, E., Kolb, H. J., Mittermüller, J. et al., Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor α (TNFα) release in the course of pretransplant conditioning: Role of conditioning regimens and prophylactic application of a monoclonal antibody neutralising human TNF α (MAK 295F). Blood 86, 890-899, 1995.
43. Griffin, D. E., McArthur, J. C., and Cornblath, D. R., Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. J. Neuroimmunol. 28, 97-109, 1990.
44. Symons, J. A., Wood, N. C., di Giovine, F. S., and Duff, G. W., Soluble CD8 in patients with rheumatic diseases. Clin. Exp. Immunol. 80, 354-359, 1990.
45. Maimone, D., and Reder, A. T., Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis. Neurology 41, 851-854, 1991.
46. Carrieri, P. B., Soscia, E., Iacovitti, B. et al., Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. Eur. Cytokine Netw. 3, 495-498, 1992.
47. Hanlon, D. J., Berger, C. L., and Edelson, R. L., Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int. J. Cancer 78, 70-75, 1998.
48. Berger, C. L., Wang, N., Christensen, I., Longley, J., Heald, P., and Edelson, R. L., The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens. J. Invest. Dermatol. 107, 392-397, 1996.